634 EVEREST-1: A seamless phase 1/2 study of CEA logic-gated Tmod CAR T-cell therapy (A2B530) in patients with solid tumors associated with CEA expression also exhibiting HLA loss of heterozygosity (LOH)

• Sarah Nikiforow,
• Yi Lin,
• Marcela Maus,
• Armen Mardiros,
• Frederick L Locke,
• Scott Kopetz,
• Matthew Frigault,
• David Maloney,
• Jeffrey Ward,
• Jennifer Specht,
• Edward Garon,
• Diane M Simeone,
• John Welch,
• Kedar Kirtane,
• Marwan Fakih,
• Julian Molina,
• Kirstin Liechty,
• Ariane Lozac’hmeur,
• J Randolph Hecht,
• Caleb Smith,
• Salman R Punekar,
• Theodore Welling,
• M Pia Morelli,
• Patrick M Grierson,
• Sandip P Patel,
• Wen-Kai Weng,
• Tomislav Dragovich,
• Judy Vong,
• William Y Go,
• Eric W Ng

Affiliations

Sarah Nikiforow

Aff3 0000 0001 2106 9910grid.65499.37Division of Hematologic MalignanciesDana-Farber Cancer Institute Boston MA USA

Yi Lin

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA

Marcela Maus

11Massachusetts General Hospital, Boston, MA, USA

Armen Mardiros

Aff1 grid.410425.60000000404218357Hematology & Hematopoietic Cell TransplantationBeckman Research Institute and City of Hope National Medical Center Duarte CA USA

Frederick L Locke

Department of Blood & Marrow Transplant and Cellular Immunotherapy, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Scott Kopetz

GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Matthew Frigault

5Massachusetts General Hospital, Somerville, MA, USA

David Maloney

14Fred Hutchinson Cancer Center, Seattle, WA, USA

Jeffrey Ward

3Washington University School of Medicine and Siteman Cancer Center, Saint Louis, MO, USA

Jennifer Specht

2Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Edward Garon

David Geffen School of Medicine, UCLA, University of California Los Angeles, Los Angeles, California, USA

Diane M Simeone

1Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA

John Welch

1 Critical Care Department, University College London Hospitals NHS Foundation Trust, London, UK

Kedar Kirtane

10 H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Marwan Fakih

6 Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center Duarte, Duarte, California, USA

Julian Molina

Mayo Clinic, Rochester, MN, USA

Kirstin Liechty

2A2 Biotherapeutics, Inc., Agoura Hills, CA, USA

Ariane Lozac’hmeur

7Tempus, Chicago, IL, USA

J Randolph Hecht

9David Geffen School of Medicine at UCLA, Los Angeles, USA

Caleb Smith

Mayo Clinic, Rochester, MN, USA

Salman R Punekar

1New York University Langone Health, New York, NY, USA

Theodore Welling

1New York University Langone Health, New York, NY, USA

M Pia Morelli

4The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Patrick M Grierson

7Washington University in St. Louis, Saint Louis, MO, USA

Sandip P Patel

8University of California, San Diego, La Jolla, CA, USA

Wen-Kai Weng

13Stanford University, Stanford, CA, USA

Tomislav Dragovich

15Banner MD Anderson Cancer Center, Gilbert, AZ, USA

Judy Vong

16A2 Biotherapeutics, Inc., Agoura Hills, CA, USA

William Y Go

16A2 Biotherapeutics, Inc., Agoura Hills, CA, USA

Eric W Ng

16A2 Biotherapeutics, Inc., Agoura Hills, CA, USA